Summary & Overview

HCPCS Level II J3472: Injection, Hyaluronidase Ovine, Preservative Free

HCPCS Level II code J3472 denotes an injection of hyaluronidase, ovine, preservative free, billed per 1000 USP units. This code identifies a pharmacologic facilitator used to increase the dispersion and absorption of other injected drugs, commonly administered in outpatient clinical environments. Nationally, accurate use of J3472 matters for clear documentation of adjunctive drug administration and for payer coverage determinations tied to specific injectable therapies.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context, typical sites of service, and what to expect in payer coverage considerations. The publication provides benchmark-oriented insights where available, highlights relevant billing practices, and summarizes policy or reimbursement elements that commonly affect billing for injectable adjunct agents.

This summary is intended to orient clinicians, coders, and billing professionals to the purpose and clinical setting of J3472, and to outline the types of policy and payer interactions that typically influence claims processing and payment.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ3472HCPCS Level IIhyaluronidaseinjectable drugoutpatient servicesdrug administrationpharmacologic adjunctbiologic injectionbilling code

Billing Code Overview

HCPCS Level II code J3472 represents an injection of hyaluronidase, ovine, preservative free, per 1000 USP units. This service is a pharmacologic agent administration used to enhance diffusion and absorption of co-administered subcutaneous or intramuscular medications. The service type is injectable biologic/drug administration. The typical site of service is outpatient clinical settings where injections are given, including physician offices, ambulatory care centers, and hospital outpatient departments.

Clinical & Coding Specifications

Clinical Context

A patient presents to an outpatient ophthalmology or dermatology clinic for enzymatic dispersion of subcutaneous or periocular hyaluronic acid filler or to facilitate spread of infiltrated local anesthetic. The typical patient is an adult who received a hyaluronic acid-based cosmetic filler and now has a complication such as persistent lumping, contour irregularity, or suspected vascular compromise, or requires focal tissue dissection to improve local anesthetic distribution. The clinical workflow includes pre-procedure assessment and informed consent, focused physical exam of the treated area, photographic documentation, identifying the area of filler or tissue restriction, and preparing a preservative-free ovine hyaluronidase vial. Under aseptic technique, the provider injects measured units of J3472 (hyaluronidase, ovine, preservative free, per 1000 USP units) directly into the affected soft tissue in incremental aliquots until enzymatic effect is achieved. Post-procedure monitoring for allergic reaction, local hematoma, or infection follows. Typical settings are outpatient ambulatory surgical centers, dermatology or ophthalmology offices, or emergency departments when vascular compromise is suspected. Common payors encountered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier	When no specific modifier applies and standard reporting is appropriate.
`22`	Increased procedural services	When substantially greater work or complexity is documented for the hyaluronidase injection procedure.
`23`	Unusual anesthesia	When general anesthesia is used for an otherwise non-anesthesia procedure related to the injection.
`52`	Reduced services	When the full hyaluronidase service was partially reduced or not completed as documented.
`53`	Discontinued procedure	When the injection procedure is started but terminated due to extenuating circumstances.
`54`	Surgical care only	When reporting only the intraoperative portion separate from pre- or postoperative care.
`55`	Postoperative management only	When reporting only postoperative care related to the procedure.
`56`	Preoperative management only	When reporting only preoperative care related to the procedure.
`62`	Two surgeons	When two surgeons work together as primary surgeons on the same procedure site and each bills.
`AS`	Accredited surgical assistant	When an accredited assistant at surgery participates and must be reported where allowed.
`QX`	CRNA service with medical direction by physician	When a certified registered nurse anesthetist performs services under physician medical direction.
`QY`	Medical direction of one CRNA by an anesthesiologist	When an anesthesiologist medically directs a single CRNA for anesthesia services.
`QK`	Medical direction of two or more CRNAs	When an anesthesiologist medically directs two or more CRNAs.
`QY`	Medical direction of one CRNA by an anesthesiologist	When an anesthesiologist medically directs a single CRNA for anesthesia services.
`FY`	Location-based modifier (place of service)	When payor requires location specification for billing (use per payor rules).

Taxonomy Code	Specialty	Notes
`207Q00000X`	Dermatology	Most common specialty performing cosmetic filler revision and hyaluronidase injections.
`207W00000X`	Ophthalmology	Commonly performs periocular hyaluronidase for eyelid and periorbital filler complications.
`2083P0800X`	Plastic Surgery	Performs corrective procedures and enzymatic filler dissolution in aesthetic practice.
`207L00000X`	Otolaryngology (ENT)	Manages facial soft tissue complications and performs injections when indicated.
`225100000X`	Emergency Medicine	May administer hyaluronidase emergently for suspected vascular occlusion in ED settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`T84.7XXA`	Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, initial encounter	Relevant when foreign-body filler reaction with inflammation prompts hyaluronidase use.
`L91.5`	Scar conditions and fibrosis of skin	Relevant for treatment of palpable filler-related fibrosis or contour irregularity.
`M79.60`	Pain in unspecified limb	May be used when filler-related pain or discomfort occurs in extremity sites treated with hyaluronidase.
`I77.6`	Arterial embolism and thrombosis of lower extremity	Represents vascular compromise scenarios where enzymatic intervention is part of management when filler causes occlusion (site-specific arterial codes may supersede).
`H02.809`	Unspecified disorder of eyelid, unspecified eyelid	Used for periocular complications such as eyelid distortion from filler requiring hyaluronidase.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11900`	Injection, intralesional; up to and including 7 lesions	Used when performing multiple small intralesional injections of hyaluronidase for nodules or localized lumps.
`20550`	Injection(s); single tendon sheath, or ligament, or ganglion cyst	Used when injecting into a localized tendon sheath or cystic collection to facilitate dispersion (rarely applicable but sometimes used for soft-tissue targeted injections).
`20551`	Injection(s); single tendon sheath, or ligament, or ganglion cyst; each additional tendon sheath, or ligament, or ganglion cyst (List separately in addition to code for primary procedure)	Used when multiple adjacent soft-tissue sites require injection in the same session.
`67999`	Unlisted procedure, anterior segment of eye or ocular adnexa	Used for atypical periocular enzymatic procedures not described by specific ocular CPT codes (billed when no specific code exists).
`99100`	Anesthesia for patient of extreme age, under 1 year and over 70 (List separately)	Used when special anesthesia considerations apply for very young or elderly patients receiving procedural sedation related to hyaluronidase injection.